Cargando…

Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?

Detalles Bibliográficos
Autores principales:	Manapov, Farkhad, Niyazi, Maximilian, Li, Minglun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797278/ https://www.ncbi.nlm.nih.gov/pubmed/24137564 http://dx.doi.org/10.3857/roj.2013.31.3.175

Ejemplares similares

Moderate hypofractionated image-guided thoracic radiotherapy for locally advanced node-positive non-small cell lung cancer patients with very limited lung function: a case report
por: Manapov, Farkhad, et al.
Publicado: (2017)

In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
por: Käsmann, Lukas, et al.
Publicado: (2020)

Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy
por: Manapov, Farkhad, et al.
Publicado: (2016)

NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer
por: Manapov, Farkhad, et al.
Publicado: (2022)

Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2021)

MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients
por: Eze, Chukwuka, et al.
Publicado: (2022)

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy
por: Manapov, Farkhad, et al.
Publicado: (2013)

Optimal timing of thoracic irradiation for limited stage small cell lung cancer: Current evidence and future prospects
por: Sager, Omer, et al.
Publicado: (2022)

Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort
por: Manapov, Farkhad, et al.
Publicado: (2016)

Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2021)

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
por: Manapov, Farkhad, et al.
Publicado: (2018)

Analysis of Factors Affecting Brain Metastasis in Limited-Stage Small-Cell Lung Cancer Treated With Definitive Thoracic Irradiation
por: Wu, Shuting, et al.
Publicado: (2020)

Timing of tumor-induced atelectasis resolution and pulmonary function restoration in the course of image-guided moderate hypofractionated thoracic irradiation: a case report and mini-review of literature
por: Bodensohn, Raphael, et al.
Publicado: (2021)

Rising Star
por: Wojtys, Edward M.
Publicado: (2012)

Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer
por: Belderbos, J, et al.
Publicado: (2007)

Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis
por: Eze, Chukwuka, et al.
Publicado: (2019)

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
por: Taugner, Julian, et al.
Publicado: (2021)

A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis
por: Yan, Michael, et al.
Publicado: (2021)

PD-L1 expression on tumor cells as a potential predictive biomarker for patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab
por: Käsmann, Lukas, et al.
Publicado: (2023)

Prices Still Rising
Publicado: (1920)

Omicron still on the rise
por: Wilson, Clare
Publicado: (2022)

Involved-field radiotherapy in limited-stage small-cell lung cancer
por: Chien, C-R, et al.
Publicado: (2007)

Editorial: Rising Stars: Africa
por: Balogun, Emmanuel O., et al.
Publicado: (2022)

Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses—reply
por: Hu, Xiao, et al.
Publicado: (2020)

Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT
por: Niyazi, Maximilian, et al.
Publicado: (2013)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey
por: Käsmann, Lukas, et al.
Publicado: (2020)

Editorial: The genome’s rising star: Transfer RNA-derived small fragments
por: Yan, Wei
Publicado: (2022)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
por: Zhao, Shen, et al.
Publicado: (2018)

Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis
por: Hoffmann, Elgin, et al.
Publicado: (2023)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Old and rising stars in the lymphoid liver
por: Selmi, Carlo, et al.
Publicado: (2009)

The rising young scientist stars in China
por: Cheng, Hao
Publicado: (2016)

Editorial: Rising stars in Food Chemistry
por: Chen, Shuai, et al.
Publicado: (2022)

Editorial: Rising stars in neurorobotics 2021
por: Valle, Giacomo
Publicado: (2022)

Editorial: Catalysis rising stars in China
por: Yang, Liuqingqing, et al.
Publicado: (2023)

Editorial: Rising stars in reproduction: 2021
por: Bedoschi, Giuliano
Publicado: (2023)

Editorial: Rising stars in biofilms 2022
por: Armbruster, Chelsie E., et al.
Publicado: (2023)

Editorial: Rising stars in molecular psychiatry
por: Yang, Zhongli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ouboakotl4tjks34r3skbrljui